絞り込み

16355

広告

2073件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients with Nonvalvular Atrial Fibrillation Treated in Routine German Practice.

The Effects of Indirect- and Direct-Acting Anticoagulants on Lupus Anticoagulant Assays: A Large, Retrospective Study at a Coagulation Reference Laboratory.

Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect.

Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?

Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry.

Pharmacological Therapy in Stroke Prophylaxis - The New versus the Old Agents.

Apixaban in patients with Atrial Fibrillation: A Systematic Review.

Cost-Effective Medicines for Stroke Prophylaxis in Patients with Atrial Fibrillation.

Atrial Fibrillation and Oral Anticoagulation in Chronic Kidney Disease.

Prevention of Stroke in Patients With Atrial Fibrillation.

Appropriateness of Oral Anticoagulants for the Long-Term Treatment of Atrial Fibrillation in Older People: Results of an Evidence-Based Review and International Consensus Validation Process (OAC-FORTA 2016).

Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.

Initiation of anticoagulation in atrial fibrillation: which factors are associated with choice of anticoagulant?

[Measurement of Prothrombin Fragment 1+2 for the Assessment of Anticoagulant Activity in Patients Treated with Warfarin or Non-vitamin K Antagonist Oral Anticoagulant].

Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease.

International Normalized Ratio Is Significantly Elevated With Rivaroxaban and Apixaban Drug Therapies: A Retrospective Study.

Risk of Intracranial Hemorrhage in Ground Level Fall with Antiplatelet or Anticoagulant Agents.

Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります